Nurix Therapeutics Inc（NRIX）價格預測NRIXNurix Therapeutics Inc

Alphio's NRIX stock price prediction model matches the current Nurix Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $25.29 (-0.12%). The 1-week path is $25.59 (+1.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Nurix Therapeutics Inc appears to be a good buy right now due to its recent collaboration with Roche, which has significantly boosted its financial outlook with an upfront payment of $700 million and potential milestone payments up to $2.3 billion. The current price of $26.21 is well below the analyst price targets, with Morgan Stanley setting a target of $38, indicating a potential upside of 45%. Additionally, the stock has shown a strong year-to-date change of +45.13%, reflecting positive market sentiment. However, the main risk is the negative net income reported, which was -89,535,000 USD in Q2 2026, indicating ongoing financial challenges that investors should monitor closely.

Nurix Therapeutics Inc (NRIX) last closed at $25.32, losing -1.94%. These facts feed the 1-day and 1-week NRIX price prediction above.